财务
- Market Capitalization 274.87 M
- Employee 130
- Founded 2016
- CEO N/A
- Website www.nautilus.bio
- Headquarter Washington, United States
- FIGI BBG00W7G4M12
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.15
市销率
—
相关股票代码
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3286 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.67 USD | -0.27% | +0.27% | -3.42% | -62.40% | 280.01 M USD | ||
| 3289 | SRZN Surrozen, Inc. - Common Stock | 23.75 USD | +1.02% | -5.00% | +32.98% | +72.10% | 279.15 M USD | ||
| 3303 | CABA Cabaletta Bio, Inc. - Common Stock | 1.62 USD | -4.14% | -17.35% | -39.55% | -44.71% | 274.66 M USD | ||
| 3342 | EYPT EyePoint, Inc. - Common Stock | 3.01 USD | -1.95% | -8.79% | -17.76% | -74.92% | 259.50 M USD |